September 21, 2022 Role of tigecycline in the treatment of urinary tract infections: a systematic review of published case reports
September 13, 2022-September 14, 2022 View Now | 2022 RDCA-DAP Workshop, September 13-14 Since its launch in 2019, the Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP®) has established i
September 7, 2022 Evaluating the Use of Backup Solutions for ePRO Systems has been published in Applied Clinical Trials
August 23, 2022 Obtaining and Using TPOXX Tecovirimat for Treatment of Monkeypox An overview of how to obtain and use Tecovirimat (TPOXX) during the 2022 monkeypox public health emergency under Expanded Access I
August 17, 2022 View Now | Addressing the Gaps in Clinical Trial Readiness for FSHD Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common myopathies affecting anywhere between 1:8,000 to 1:20,000
August 12, 2022 Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies C-Path’s Type 1 Diabetes Consortium (T1DC) is pleased to announce that “Consortium-based approach to receiving an EMA...
July 26, 2022 PSTC 15-year Anniversary Webinar Series Join scientists from PSTC member companies, health authorities and other key opinion leaders during the PSTC 15-year Anniversary W
